Literature DB >> 3829189

Inhibition of rat liver glucokinase by alloxan and ninhydrin.

H Hara, I Miwa, J Okuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3829189     DOI： 10.1248/cpb.34.4731

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  5 in total

Review 1.  Alloxan: history and mechanism of action.

Authors:  S Lenzen; U Panten
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

2.  Tissue and subcellular distribution of glucokinase in rat liver and their changes during fasting-refeeding.

Authors:  Y Toyoda; I Miwa; M Kamiya; S Ogiso; T Nonogaki; S Aoki; J Okuda
Journal:  Histochem Cell Biol       Date:  1995-01       Impact factor: 4.304

3.  Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition.

Authors:  S Lenzen; F H Brand; U Panten
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

Review 4.  The mechanisms of alloxan- and streptozotocin-induced diabetes.

Authors:  S Lenzen
Journal:  Diabetologia       Date:  2007-12-18       Impact factor: 10.122

5.  Ingestion of a moderate high-sucrose diet results in glucose intolerance with reduced liver glucokinase activity and impaired glucagon-like peptide-1 secretion.

Authors:  Eriko Sakamoto; Yusuke Seino; Ayako Fukami; Naohiro Mizutani; Shin Tsunekawa; Kota Ishikawa; Hidetada Ogata; Eita Uenishi; Hideki Kamiya; Yoji Hamada; Hiroyuki Sato; Norio Harada; Yukiyasu Toyoda; Ichitomo Miwa; Jiro Nakamura; Nobuya Inagaki; Yutaka Oiso; Nobuaki Ozaki
Journal:  J Diabetes Investig       Date:  2012-10-18       Impact factor: 4.232
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.